BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 4134714)

  • 21. Migratory erythema and glucagonoma: descriptive nomenclature.
    Burgdorf WH
    Ann Intern Med; 1988 Jun; 108(6):912-3. PubMed ID: 2835921
    [No Abstract]   [Full Text] [Related]  

  • 22. Uncontrolled diabetes mellitus and hyperglucagonemia associated with an islet cell carcinoma.
    Leichter SB; Pagliara AS; Grieder MH; Pohl S; Rosai J; Kipnis DM
    Am J Med; 1975 Feb; 58(2):285-93. PubMed ID: 46704
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of somatostatin in necrolytic migratory erythema of glucagonoma.
    Elsborg L; Glenthøj A
    Acta Med Scand; 1985; 218(2):245-9. PubMed ID: 2865872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Necrolytic migratory erythema: glucagonoma syndrome. Clinical and histological aspects].
    Wilkinson DS
    Ann Med Interne (Paris); 1984; 135(8):654-7. PubMed ID: 6099068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The glucagonoma syndrome (necrolytic migratory erythema) and zinc.
    Amon RB; Swenson KH; Hanifin JM; Hambidge KM
    N Engl J Med; 1976 Oct; 295(17):962. PubMed ID: 184387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Necrolytic migratory erythema in glucagonoma syndrome (author's transl)].
    Kitoh M; Ohyama K; Shigeo ; Arao AT
    Nihon Hifuka Gakkai Zasshi; 1981 Apr; 91(5):559-68. PubMed ID: 6270429
    [No Abstract]   [Full Text] [Related]  

  • 27. [Glucagonoma syndrome].
    Tellechea O; Baptista AP
    Acta Med Port; 1988; 1(2):149-52. PubMed ID: 2849866
    [No Abstract]   [Full Text] [Related]  

  • 28. The glucagonoma syndrome.
    Lewis AE
    Int J Dermatol; 1979; 18(1):17-22. PubMed ID: 216645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid.
    Peterson LL; Shaw JC; Acott KM; Mueggler PA; Parker F
    J Am Acad Dermatol; 1984 Sep; 11(3):468-73. PubMed ID: 6090515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cure of insulin-dependent diabetes mellitus by removal of a glucagonoma.
    Lightman SL; Bloom SR
    Br Med J; 1974 Mar; 1(5904):367-8. PubMed ID: 4362100
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucagonoma syndrome.
    Hashizume T; Kiryu H; Noda K; Kano T; Nakano R
    J Am Acad Dermatol; 1988 Aug; 19(2 Pt 2):377-83. PubMed ID: 2842381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Images in clinical medicine. Necrolytic migratory erythema.
    McGevna L; Tavakkol Z
    N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
    [No Abstract]   [Full Text] [Related]  

  • 33. [Glucagonoma syndrome in a multihormonal pancreatic tumor].
    Keller U; Fankhauser S; Schumacher A; Trimble ER; Heitz PU
    Schweiz Med Wochenschr; 1982 Feb; 112(9):297-304. PubMed ID: 6281878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The glucagonoma syndrome and its management.
    Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1977; 9(5):419-24. PubMed ID: 201809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic studies and glucagon gel filtration pattern before and after surgery in a case of glucagonoma syndrome.
    von Schenck H; Thorell JI; Berg J; Bojs G; Dymling JF; Hallengren B; Ljungberg O; Tibblin S
    Acta Med Scand; 1979; 205(3):155-62. PubMed ID: 218426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glucagonoma tumors and syndrome.
    Montenegro-Rodas F; Samaan NA
    Curr Probl Cancer; 1981 Dec; 6(6):1-54. PubMed ID: 6276079
    [No Abstract]   [Full Text] [Related]  

  • 37. Demonstration of glucagon in islet cell adenomas of the pancreas by immunofluorescent technic.
    Lomský R; Langr F; Vortel V
    Am J Clin Pathol; 1969 Feb; 51(2):245-50. PubMed ID: 4304016
    [No Abstract]   [Full Text] [Related]  

  • 38. [Necrolytic migratory erythema revealing glucagonoma without diabetes].
    Marty C; Bennet A; Bayle P; Danjoux M; Lalande T; Marguery MC; Bazex J
    Ann Med Interne (Paris); 2003 Dec; 154(8):552-6. PubMed ID: 15037834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of somatostatin and somatostatin analogs in a patient with a glucagonoma.
    Kahn CR; Bhathena SJ; Recant L; Rivier J
    J Clin Endocrinol Metab; 1981 Sep; 53(3):543-9. PubMed ID: 6114963
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucagonoma, chronic recurrent peptic ulcer disease, and enhanced amylase-creatinine clearance ratio. Report of a case with review of the literature.
    Pitchumoni CS; Thelmo W; Ahmed KS; Kumar A; Davidian M; Einhorn R; Adler J; McCarthy J
    J Clin Gastroenterol; 1979 Sep; 1(3):219-23. PubMed ID: 95410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.